BREAKING
NVIDIA (NVDA) eyes China AI chip re-entry as export licensing shifts to case-by-case review 2 days ago Qualcomm (QCOM) authorizes $20B stock repurchase program, raises quarterly dividend to $0.92 2 days ago UP Fintech Holding Limited Reports Strong 2025 Results 2 days ago FedEx (FDX) Q3 Earnings Crush Estimates: EPS of $5.25 Beats by 27% on $24B Revenue 2 days ago Cato Corporation 2025 Financial Results Summary 2 days ago GROY Posts Breakeven Q4 Earnings, Beating Estimates by 100% as Revenue Grows 34.2% YoY to $4.5M 2 days ago York Space Systems (YSS) Posts -$0.24 EPS vs. -$0.18 Est., Revenue Soars to $105.3M 2 days ago Scholastic (SCHL) Q3 Loss Narrows to $0.15/Share vs $0.36 Estimate, Revenue Misses at $329.1M 2 days ago Curis (CRIS) EPS Soars 210.8% to $1.23, But Revenue Plunges 67.1% to $1.1M 2 days ago Eton Pharmaceuticals (ETON) Q4 Revenue Surges 82.9% YoY to $21.3M, EPS Climbs 266.7% 2 days ago NVIDIA (NVDA) eyes China AI chip re-entry as export licensing shifts to case-by-case review 2 days ago Qualcomm (QCOM) authorizes $20B stock repurchase program, raises quarterly dividend to $0.92 2 days ago UP Fintech Holding Limited Reports Strong 2025 Results 2 days ago FedEx (FDX) Q3 Earnings Crush Estimates: EPS of $5.25 Beats by 27% on $24B Revenue 2 days ago Cato Corporation 2025 Financial Results Summary 2 days ago GROY Posts Breakeven Q4 Earnings, Beating Estimates by 100% as Revenue Grows 34.2% YoY to $4.5M 2 days ago York Space Systems (YSS) Posts -$0.24 EPS vs. -$0.18 Est., Revenue Soars to $105.3M 2 days ago Scholastic (SCHL) Q3 Loss Narrows to $0.15/Share vs $0.36 Estimate, Revenue Misses at $329.1M 2 days ago Curis (CRIS) EPS Soars 210.8% to $1.23, But Revenue Plunges 67.1% to $1.1M 2 days ago Eton Pharmaceuticals (ETON) Q4 Revenue Surges 82.9% YoY to $21.3M, EPS Climbs 266.7% 2 days ago
ADVERTISEMENT
Market News

Crocs (NASDAQ: CROX): Q3 2019 Earnings Snapshot

— Crocs Inc. (NASDAQ: CROX) reported its third-quarter 2019 earnings of $0.51 per share and adjusted earnings of $0.57 per share. This is compared to the analysts’ expectations of $0.40 per share. — Revenues grew by 20% to $312.8 million versus $302.06 million expected. Currencies negatively impacted revenue by about $3 million while store closures […]

October 30, 2019 1 min read
Alphastreet Vertex Pharma Q4 2025 Earnings Results

— Crocs Inc. (NASDAQ: CROX) reported its third-quarter 2019 earnings of $0.51 per share and adjusted earnings of $0.57 per share. This is compared to the analysts’ expectations of $0.40 per share. — Revenues grew by 20% to $312.8 million versus $302.06 million expected. Currencies negatively impacted revenue by about $3 million while store closures […]

— Crocs Inc. (NASDAQ: CROX) reported its third-quarter 2019 earnings of $0.51 per share and adjusted earnings of $0.57 per share. This is compared to the analysts’ expectations of $0.40 per share.

— Revenues grew by 20% to $312.8 million versus $302.06 million expected. Currencies negatively impacted revenue by about $3 million while store closures reduced the top line by about $4 million.

Earnings Update by AlphaStreet

— Wholesale revenues increased by 25.4%, e-commerce revenues grew by 28.2%, and retail comparable store sales advanced by 12.5%.

— Looking ahead into the fourth quarter, the company predicts revenue in the range of $245 million to $255 million compared to $216 million in the fourth quarter of 2018.

— For the full year 2019, the company lifted its revenue growth outlook to the range of 11% to 12% over 2018 revenue of $1.09 billion, compared to the prior estimate of 9% to 11%. The top line will be negatively impacted by currency changes and store closures.

— Capital expenditures are now anticipated to be about $60 million for the full year, lower than the previous forecast of about $65 million.

— With respect to 2020 revenues, the company expects 12% to 14% growth over 2019 revenues. This estimate assumes that currency will negatively impact results by about $10 million.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

ADVERTISEMENT